First Republic Investment Management, Inc. Sorrento Therapeutics, Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$4.65 - $7.23 $120,142 - $186,801	-25,837 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.41 - $10.99 $191,452 - $283,948	25,837 New	25,837 $197,000
Q3 2019 Nov 08, 2019	SELL	$2.05 - $2.69 $87,514 - $114,836	-42,690 Closed	0 $0
Q1 2019 Apr 30, 2019	SELL	$1.86 - $5.94 $8,667 - $27,680	-4,660 Reduced 9.84%	42,690 $203,000
Q4 2018 Feb 12, 2019	SELL	$2.01 - $4.24 $95,173 - $200,764	-47,350 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$4.22 - $7.5 $199,817 - $355,125	47,350 New	47,350 $208,000
Q2 2018 Aug 14, 2018	BUY	$4.75 - $8.0 $47,500 - $80,000	10,000 Added 16.04%	72,350 $521,000
Q1 2018 May 10, 2018	SELL	$4.5 - $9.95 $58,500 - $129,349	-13,000 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$1.75 - $3.8 $22,750 - $49,400	13,000	13,000 $49,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account